期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

冠心病患者同型半胱氨酸水平的临床意义 被引量：3

下载PDF
导出
摘要 目的检测同型半胱氨酸在冠心病患者中的浓度水平,并推测其临床意义。方法将临床诊断为冠心病患者175例,分为急性冠脉综合征(19例),稳定型心绞痛(56例)组,与非冠心病(136例)作对照,分别测定血清同型半胱氨酸水平,除外高血压、糖尿病、脑血管疾病等其他危险因素的影响。结果比较Hcy水平在冠心病组与对照组中分布,发现在冠心病组中无明显升高。结论血清Hcy预测冠心病的危险可能性不大。
作者 王蓉 胡东南 裴娟慧 陆慧
机构地区 北京航天总医院
出处 《中西医结合心脑血管病杂志》 2015年第3期351-352,共2页 Chinese Journal of Integrative Medicine on Cardio-Cerebrovascular Disease
关键词 冠心病 同型半胱氨酸水平 总胆固醇水平
分类号 R541.4 [医药卫生—心血管疾病]
  • 相关文献

参考文献8

  • 1Shai I,Stampfer H,Hauer R, et al. Homocysteine as a risk fac- tor for coronary heart diseases and its association with inflam- matory biomarkers. Lipids and dietary factors [J]. Atherosclero- sis,2007,177(1) :375 - 318.
  • 2张化勇,杨帆,魏经汉,张静华,赵洛沙.血清同型半胱氨酸与冠心病的相关性研究[J].中国循证心血管医学杂志,2012,4(1):46-48. 被引量：104
  • 3蒋珍妮,俞锋.同型半胱氨酸与心血管疾病关系的研究进展[J].心脏杂志,2000,12(3):216-218. 被引量：32
  • 4Biselli PM,Guerzoni AR, Godoy MF, et al. Genetic polymor phisms involved in folate metabolism and concentrations of methylmalonic acid and folate plasma homocysteine and risk of coronary artery disease[J]. Thromb Th rombolysis, 2010,29: 32 - 40.
  • 5Hansrani M,Stansby G. The use of an in vivo model to study the effects of hypeihomoeysteinacmia on vascular function [J]. [J]Surg Res,2008,145:13 - 18.
  • 6Evans RW,Shaten BJ ,Hempel JD , eta/. Homocyst(e)ine and risk of cardiovascular disease in the Multiple Risk Factor Inter- vention Trial[J]. Arterioscler Thromb Vasc Biol, 2007, 17(10) : 1947 1953.
  • 7Ford ES, Smith SJ , Stroup DF, et al. Homocysteine and cardio- vascular disease,A systematic review of the evidence with spe cial emphasis on case - control studies and nested case - control studies[J]. Int [J]Epidemiol,2002:3159 - 3170.
  • 8Homocysteine Studies Collaboration. Homocysteine and risk of ischemic heart disease and stroke:A meta- analysis [J]. JAMA, 2002, 288 : 2015 - 2022.

二级参考文献44

  • 1刘伟峰,张步延,黄文增,关红菁.高同型半胱氨酸血症致血管炎症作用[J].中国动脉硬化杂志,2005,13(4):464-466. 被引量：32
  • 2黄海威,郭明辉,黄家星,林锐金,张颖,陈亚利.1020名社区人群同型半胱氨酸水平的调查和相关分析[J].中华流行病学杂志,2006,27(8):721-724. 被引量：42
  • 3陆再英,钟南山.内科学[M].第7版.北京:人民卫生出版社.2010:27-28.
  • 4陈健,张陆,陈柏楠.同型半胱氨酸致动脉粥样硬化机制的研究进展[C].中华中医药学会周围血管病分会学术大会论文集(二).北京:中华中医药学会,2009.
  • 5Wilcken DE,Wilcken B.The pathogenesis of coronary artery dis-ease A possible role form ethionine metabolism[J].J Clin Invest,1976,57(4):1079-1082.
  • 6De Bree A,Verschuren WM,Kromhout D,et al.Homocysteine de-terminants and the evidence to what extent homocysteine determinesthe risk of coronary heart disease[J].Pharmacological reviews,2002,54(4):599-618.
  • 7Yagura C,Takamura N,Kadota K,et al.Evaluation of cardiovascu-lar risk factors and related clinical markers in healthy young Japa-nese adults[J].Clin Chemlab Med,2007,45(2):220-225.
  • 8Johnson JL,Baker AH,Kazuhiro Oka,et al.Suppression of athero-sclerotic plaque progression and instability by tissue inhibitor ofmetalloproteinase involvement of macrophage migration and apopto-sis[J].Circulation,2006,113(20):435-444.
  • 9Wu MH,Wang JH,Lai CP,et al.Association of hs-CRP with theSeverity of Coronary Artery Disease and Myocardial Infarction[J].Int J Cardiol,2004,97(Suppl2):47-49.
  • 10Takano M,Inami S,Ishibashi F,et al.Angioscopic follow-up studyof coronary ruptured plaques in nonculprit lesions[J].J Am CollCardiol,2005,45(5):652-658.

共引文献134

同被引文献51

  • 1中华人民共和国卫生部.中药新药临床研究指导原则[M].北京:中国医药科技出版社,2002.115-119.
  • 2葛均波,钟南山.内科学[M].8版.北京:人民卫生出版社,2013:21.
  • 3中国老年学学会心脑血管病专业委员会,中国医师协会循证医学专业委员会.老年高血压的诊断与治疗中国专家共识(2011版).中国心血管病研究,2011,9:801-808.
  • 4中华中医药学会.中医内科常见病诊疗指南中医部分[M].北京:中国中医药出版社,2008:39-42.
  • 5Bakirci EM, Degirmenci H, Hamur H, et al. New inflammatory markers for prediction of non-dipper blood pressure pattern in patients with essential hypertension: Serum YKL-40/Chitinase 3- like protein 1 levels and echocardiographic epicardial adipose tis- sue thickness. Clin Exp Hypertens, 2015,28:1-6.
  • 6Yagi S, Takashima A, Mitsugi M, et al. Effect of combination tablets containing amlodipine 10 mg and irbesartan 100 mg on blood pressure and cardiovascular risk factors in patients with hypertension. Ther Clin Risk Manag,2015,12:83-88.
  • 7Parchim NF, Wang W, Iriyama T, et al. Neurokinin 3 receptor and phosphocholine transferase: missing factors for pathogenesisof C-reactive protein in preeclampsia. Hypertension,2015,65: 430-439.
  • 8Wang C, Han L, Wu Q, et al. Association between homocys- teine and incidence of ischemic stroke in subjects with essential hypertension: a matched case-control study. Clin Exp Hyper- tens ,2015,20: 1-6.
  • 9Catena C, Colussi G, Url-Michitsch M, et al. Subclinical carotid artery disease and plasma homocysteine levels in patients with hypertension. J Am Soc Hypertens, 2015,9 : 167-175.
  • 10Temple M E,Luzier A B,Kazierad D J.Homocyateine as a risk factor for atherosclerosis[J].Annals of Phamacotherapy,2000,3(1):57-65.

引证文献3

二级引证文献28

中西医结合心脑血管病杂志
2015年 第3期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部